- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour suppressor TRIM33 targets nuclear β-catenin degradation
Authors
Keywords
-
Journal
Nature Communications
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-02-02
DOI
10.1038/ncomms7156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β–dependent cancer metastasis
- (2014) Jianfei Xue et al. JOURNAL OF CLINICAL INVESTIGATION
- CUL3 and protein kinases: Insights from PLK1/KLHL22 interaction
- (2013) Thibaud Metzger et al. CELL CYCLE
- Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?
- (2013) James A Nathan et al. EMBO JOURNAL
- Tripartite Motif-containing 33 (TRIM33) Protein Functions in the Poly(ADP-ribose) Polymerase (PARP)-dependent DNA Damage Response through Interaction with Amplified in Liver Cancer 1 (ALC1) Protein
- (2013) Atul Kulkarni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- c-Cbl, a Ubiquitin E3 Ligase That Targets Active β-Catenin
- (2013) Vipul Chitalia et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacological modulation of beta-catenin and its applications in cancer therapy
- (2013) Ravi Thakur et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Protein Kinase C Delta Negatively Modulates Canonical Wnt Pathway and Cell Proliferation in Colon Tumor Cell Lines
- (2013) José G. Hernández-Maqueda et al. PLoS One
- Wnt Stabilization of -Catenin Reveals Principles for Morphogen Receptor-Scaffold Assemblies
- (2013) S.-E. Kim et al. SCIENCE
- Tif1γ Suppresses Murine Pancreatic Tumoral Transformation by a Smad4-Independent Pathway
- (2012) David F. Vincent et al. AMERICAN JOURNAL OF PATHOLOGY
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- The many faces and functions of β-catenin
- (2012) Tomas Valenta et al. EMBO JOURNAL
- Transcriptional intermediary factor 1γ binds to the anaphase-promoting complex/cyclosome and promotes mitosis
- (2012) G G Sedgwick et al. ONCOGENE
- FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
- (2011) Nu Zhang et al. CANCER CELL
- EGFR Signaling Regulates Tumor Cell Migration in Craniopharyngiomas
- (2011) A. Holsken et al. CLINICAL CANCER RESEARCH
- Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia
- (2011) Romain Aucagne et al. JOURNAL OF CLINICAL INVESTIGATION
- Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
- (2011) Weiwei Yang et al. NATURE
- A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells
- (2011) G Zhu et al. ONCOGENE
- Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma
- (2011) B. Herquel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TIF1γ Controls Erythroid Cell Fate by Regulating Transcription Elongation
- (2010) Xiaoying Bai et al. CELL
- FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination
- (2009) Sirio Dupont et al. CELL
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Inactivation of TIF1γ Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas
- (2009) David F. Vincent et al. PLoS Genetics
- Molecular Basis for the Critical Role of Suppressor of Cytokine Signaling-1 in Melanoma Brain Metastasis
- (2008) F.-J. Huang et al. CANCER RESEARCH
- Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling
- (2008) Ximei Wu et al. CELL
- Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHL
- (2008) Vipul C. Chitalia et al. NATURE CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started